人病毒体
失调
胃肠道
发病机制
生物
疾病
旁观者效应
免疫学
炎症性肠病
肠道菌群
医学
基因组
病理
遗传学
生物化学
基因
作者
Hein M. Tun,Ye Peng,Luca Massimino,Zhen Ye Sin,Tommaso Lorenzo Parigi,Amanda Facoetti,Shaila Rahman,Silvio Danese,Federica Ungaro
出处
期刊:Gut
[BMJ]
日期:2023-11-10
卷期号:73 (2): 350-360
被引量:93
标识
DOI:10.1136/gutjnl-2023-330001
摘要
OBJECTIVE: The gut virome is a dense community of viruses inhabiting the gastrointestinal tract and an integral part of the microbiota. The virome coexists with the other components of the microbiota and with the host in a dynamic equilibrium, serving as a key contributor to the maintenance of intestinal homeostasis and functions. However, this equilibrium can be interrupted in certain pathological states, including inflammatory bowel disease, causing dysbiosis that may participate in disease pathogenesis. Nevertheless, whether virome dysbiosis is a causal or bystander event requires further clarification. DESIGN: This review seeks to summarise the latest advancements in the study of the gut virome, highlighting its cross-talk with the mucosal microenvironment. It explores how cutting-edge technologies may build upon current knowledge to advance research in this field. An overview of virome transplantation in diseased gastrointestinal tracts is provided along with insights into the development of innovative virome-based therapeutics to improve clinical management. RESULTS: , has been shown to impact intestinal immunity and barrier functions, influencing overall intestinal homeostasis. Although emerging innovative technologies still need further implementation, they display the unprecedented potential to better characterise virome composition and delineate its role in intestinal diseases. CONCLUSIONS: The field of gut virome is progressively expanding, thanks to the advancements of sequencing technologies and bioinformatic pipelines. These have contributed to a better understanding of how virome dysbiosis is linked to intestinal disease pathogenesis and how the modulation of virome composition may help the clinical intervention to ameliorate gut disease management.
科研通智能强力驱动
Strongly Powered by AbleSci AI